263 related articles for article (PubMed ID: 29582249)
1. Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick
Paik J; Scott LJ; Pleasants RA
Clin Drug Investig; 2018 May; 38(5):463-473. PubMed ID: 29582249
[TBL] [Abstract][Full Text] [Related]
2. A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
Mansfield L; Yiu G; Sakov A; Liu S; Caracta C
Allergy Asthma Proc; 2017 Jul; 38(4):264-276. PubMed ID: 28540844
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
Sher LD; Yiu G; Sakov A; Liu S; Caracta CF
Allergy Asthma Proc; 2017 Sep; 38(5):343-353. PubMed ID: 28639542
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older.
Raphael G; Yiu G; Sakov A; Liu S; Caracta C
J Asthma; 2018 Jun; 55(6):640-650. PubMed ID: 28763243
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma.
Nugent C; Yiu G; Song S; Caracta C
J Asthma; 2018 Aug; 55(8):898-906. PubMed ID: 28933971
[TBL] [Abstract][Full Text] [Related]
6. Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma.
Miller DS; Yiu G; Hellriegel ET; Steinfeld J
Allergy Asthma Proc; 2016 Jul; 37(4):291-301. PubMed ID: 27216137
[TBL] [Abstract][Full Text] [Related]
7. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: A randomized, controlled, dose-ranging study.
Bernstein DI; Gillespie M; Song S; Steinfeld J
J Asthma; 2017 Aug; 54(6):559-569. PubMed ID: 27937064
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Reynolds NA; Lyseng-Williamson KA; Wiseman LR
Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
[TBL] [Abstract][Full Text] [Related]
10. Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids.
Kerwin EM; Gillespie M; Song S; Steinfeld J
J Asthma; 2017 Jan; 54(1):89-98. PubMed ID: 27285965
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
[TBL] [Abstract][Full Text] [Related]
12. A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study.
Kupczyk M; Majak P; Kuna P; Asankowicz-Bargiel B; Barańska E; Dobek R; Garbicz S; Jerzyńska J; Latos A; Machowiak W; Majorek-Olechowska B; Olech-Cudzik A; Poziomkowska-Gęsicka I; Rulewicz-Warniełło M; Świderska A; Tarnowski M; Kopyto P
Respir Med; 2021 Jan; 176():106274. PubMed ID: 33276251
[TBL] [Abstract][Full Text] [Related]
13. Clinical Response and Cost-Savings Associated With Generic Fluticasone Propionate/Salmeterol Multidose, Dry-Powder Inhaler in Asthma Patients Managed in an Ambulatory Care Practice Setting.
McCarthy P; Iliadis T; Zaiken K
J Pharm Pract; 2022 Apr; 35(2):274-280. PubMed ID: 33161797
[TBL] [Abstract][Full Text] [Related]
14. A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products.
Allan R; Haughie S; Ahrens R; Singh S; Ward J
J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):352-363. PubMed ID: 31259673
[No Abstract] [Full Text] [Related]
15. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
Chan R; Sousa AR; Mallett S; Hynds P; Homayoun-Valiani F; Tabberer M; Mehta R
Pulm Pharmacol Ther; 2016 Dec; 41():19-24. PubMed ID: 27599598
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
Vutikullird AB; Gillespie M; Song S; Steinfeld J
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
[TBL] [Abstract][Full Text] [Related]
17. Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma.
Ng D; Kerwin EM; White MV; Miller SD; Haughie S; Ward JK; Allan R
J Aerosol Med Pulm Drug Deliv; 2020 Apr; 33(2):99-107. PubMed ID: 31634023
[No Abstract] [Full Text] [Related]
18. Salmeterol/fluticasone propionate: a review of its use in asthma.
McKeage K; Keam SJ
Drugs; 2009; 69(13):1799-828. PubMed ID: 19719334
[TBL] [Abstract][Full Text] [Related]
19. A Dose-Response Study to Examine the Methodology for Demonstrating the Local Therapeutic Equivalence of the Fluticasone Propionate Component of an Orally Inhaled Combination Therapy of Fluticasone Propionate/Salmeterol Dry Powder.
Allan R; Haughie S; Kerwin E; Ward J
J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):364-373. PubMed ID: 31259655
[No Abstract] [Full Text] [Related]
20. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
Lyseng-Williamson KA; Plosker GL
Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]